Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 13 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 1 country.
Jia WuTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0003-3467-3433
Zai-Qi ZhangHunan Provincial Key Laboratory of Dong Medicine, Hunan University of Medicine, Huaihua 418000, China.
Xu-Dong ZhouTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0001-7445-5428
Qing-Ying YaoTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Zhu-Liang ChenTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Ling-Ling ChuTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Huang-He YuTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Yu-Pei YangTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Bin LiTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Wei WangTCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0003-0876-2205
Hunan University of Traditional Chinese Medicine · CNHunan University · CN
Funding
Hunan Provincial Key Laboratory Platform Construction Project of Dong Medicine Research 2017CT5025Hunan Provincial Key Laboratory Project of Dong Medicine Research 2015TP1020-04Open Project of Hunan Provincial Key Laboratory of Dong Medicine Research YS2019YFE012440Scientific project of Hunan Provincial Health Commission 202113052008
6 · The paper itself
Abstract
Two new A-ring contracted triterpenoids, madengaisu A and madengaisu B, and one undescribed
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.